Framework for bioethical assessment of an article on therapy

Journal of Neurosurgery

Volumn 98, Issue 3, 2003, Pages 485-490

  Bernstein, Mark ^a   Upshur, Ross E G ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b NONE

Author keywords

Ethical assessment framework; Evidence based medicine; Informed consent; Randomized controlled trial

Indexed keywords

ARTICLE; CLINICAL RESEARCH; ETHICS; EVIDENCE BASED MEDICINE; HUMAN; INFORMED CONSENT; PATIENT SELECTION; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RANDOMIZATION; STATISTICAL ANALYSIS;

EID: 0037373119     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.3.0485     Document Type: Article

References (71)

1. Altman DG: The scandal of poor medical research. Br Med J 308: 283-284, 1994
2. Angell M: Is academic medicine for sale? N Engl J Med 342: 1516-1518, 2000
3. Appelbaum PS, Roth LH, Lidz CW, et al: False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 17:20-24, 1987
4. Bampoe J, Siomin V, Bernstein M: Quality-of-life assessment in neurosurgical patients. Neurosurg Q 12:132-141, 2002
5. Baram M: Making clinical trials safer for human subjects. Am J Law Med 27:253-282, 2001
6. Barker FG II, Chang SM, Larson DA, et al: Age and radiation response in glioblastoma multiforme. Neurosurgery 49: 1288-1298, 2001
7. Baum M, Houghton J, Abrams K: Early stopping rules - clinical perspectives and ethical considerations. Stat Med 13:1459-1472, 1994
8. Bernstein M, Lumley M, Davidson G, et al: Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma. J Neurooncol 17:253-260, 1993
9. Bevan JC: Ethical behavior of authors in biomedical journalism. Ann R Coll Physicians Surg Can 35:81-85, 2002
10. Brody JL, Gluck JP, Aragon AS: Participants' understanding of the process of psychological research: informed consent. Ethics Behav 7:285-298, 1997
11. Cattorini P, Mordacci R: The physician as caregiver and researcher. Thyroidology 5:73-76, 1993
12. Chan KBY, Man-Son-Hing M, Molnar FJ, et al: How well is the clinical importance of study results reported? An assessment of randomized controlled trials. CMAJ 165:1197-1202, 2001
13. Cho MK, Shohara R, Schissel A, et al: Policies on faculty conflicts of interest at US universities. JAMA 284:2203-2208, 2000
14. Cocking D, Oakley J: Medical experimentation, informed consent and using people. Bioethics 8:293-311, 1994
15. Cox DE, Sipprelle CN: Coercion in participation as a research subject. Am Psychol 26:726-728, 1971
16. Davidoff F, DeAngelis CD, Drazen JM et al: Sponsorship, authorship, and accountability. Lancet 358:854-856, 2001
17. DeAngelis CD, Fontanarosa PB, Flanagin A: Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 286:89-91, 2001
18. Deber RB, Kraetschmer N, Irvine J: What role do patients wish to play in treatment decision making? Arch Intern Med 156: 1414-1420, 1996
19. Dennison DK: Components of a randomized clinical trial. J Periodontal Res 32:430-438, 1997
20. Djulbegovic B, Clarke M: Ethical issues in the reporting of clinical trials. JAMA 286:1577-1578, 2001 (Letter)
21. Doyle C, Crump M, Pintilie M, et al: Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol 19:1266-1274, 2001
22. Elks ML: Conflict of interest and the physician-researcher. J Lab Clin Med 126:19-23, 1995
23. Emanuel EJ, Wendler D, Grady C: What makes clinical research ethical? JAMA 283:2701-2711, 2000
24. Engelhardt HT Jr: Basic ethical principles in the conduct of biomedical and behavioral research involving human subjects. Tex Rep Biol Med 38:139-168, 1979
25. Ferguson PR: Patients' perceptions of information provided in clinical trials. J Med Ethics 28:45-48, 2002
26. Gifford AL, Cunningham WE, Heslin KC, et al: Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med 346:1373-1382, 2002
27. Goodyear-Smith F, Lobb B, Davies G, et al: International variation in ethics committee requirements: comparisons across five Westernised nations. BMC Med Ethics 3:2, 2002
28. Guyatt GH, Sackett DL, Cook DJ: Users' guides to the medical literature. II. How to use an article about therapy or prevention A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 270:2598-2601, 1993
29. Guyatt GH, Sackett DL, Cook DJ: Users' guides to the medical literature. II. How to use an article about therapy or prevention B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 271: 59-63, 1994
30. Halpern SD, Karlawish JHT, Berlin JA: The continuing unethical conduct of underpowered clinical trials. JAMA 288:258-262, 2002
31. Horton R: The clinical trial: deceitful, disputable, unbelievable, unhelpful, and shameful - what next? Control Clin Trials 22: 593-604, 2001
32. Hutchison C: Phase I trials in cancer patients: participants' perceptions. Eur J Cancer Care 7:15-22, 1998
33. Joffe S, Cook EF, Cleary PD, et al: Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 358: 1772-1777, 2001
34. Karras DJ, Sammon ME, Terregino CA, et al: Clinicially meaningful changes in quantitative measures of asthma severity. Acad Emerg Med 7:327-334, 2000
35. Kassirer JP: Financial conflict of interest: an unresolved ethical frontier. Am J Law Med 27:149-162, 2001
36. Killen J, Grady C, Folkers GK, et al: Ethics of clinical research in the developing world. Nat Rev Immunol 2:210-215, 2002
37. King TE Jr: Racial disparities in clinical trials. N Engl J Med 346: 1400-1402, 2002
38. Koller M, Lorenz W, Wagner K, et al: Expectations and quality of life of cancer patients undergoing radiotherapy. J R Soc Med 93: 621-628, 2000
39. Laperriere NJ, Leung PMK, McKenzie S, et al: Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41:1005-1011, 1998
40. Lebacqz K, Levine RJ: Respect for persons and informed consent to participate in research. Clin Res 25:101-107, 1977
41. Levine C: Has AIDS changed the ethics of human subjects research? Law Med Health Care 16:167-173, 1988
42. Levine RJ: Clinical trials and physicians as double agents. Yale J Biol Med 65:65-74, 1992
43. Levine RJ: Consent issues in human research, in Reich WT (ed): Encyclopedia of Bioethics. New York: Simon and Schuster MacMillan, 1995, pp 1241-1250
44. Lidz CW, Meisel A, Osterweis M, et al: Barriers to informed consent. Ann Intern Med 99:539-543, 1983
45. Lidz CW, Mulvey EP, Hoge SK, et al: Sources of coercive behaviors in psychiatric admissions. Acta Psychiatr Scand 101:73-79, 2000
46. Lo B, Wolf LE, Berkeley A: Conflict-of-interest policies for investigators in clinical trials. N Engl J Med 343:1616-1620, 2000
47. Marshall E: When does intellectual passion become conflict of interest? Science 257:620-623, 1992
48. McKneally MF, Martin DK: An entrustment model of consent for surgical treatment of life-threatening illness: perspective of patients requiring esophagectomy. J Thorac Cardiovasc Surg 120: 264-269, 2000
49. Meisel A, Roth LH: What we do and do not know about informed consent. JAMA 246:2473-2477, 1981
50. Menges RJ: Openness and honesty versus coercion and deception in psychological research. Am Psychol 28:1030-1034, 1973
51. Micetich KC, Thomasma DC: The ethics of patient requests in experimental medicine. CA Cancer J Clin 34:118-120, 1984
52. Miller FG, Rosenstein DL, DeRenzo EG: Professional integrity in clinical research. JAMA 280:1449-1454, 1998
53. Moher D, Schulz KF, Altman D: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285:1987-1991, 2001
54. Montaner JSG, O'Shaughnessy MV, Schecter MT: Industry-sponsored clinical research: a double-edged sword. Lancet 358: 1893-1895, 2001
55. Naylor CD: Early Toronto experience with new standards for industry-sponsored clinical research: a progress report. Can Med Assoc J 166:453-456, 2002
56. Peloso PM, Riley ML: Controlled clinical trials and clinical patient-care: sometimes in conflict. Ann R Coll Physicians Surg Can 31:372-374, 1998
57. Peto V, Jenkinson C, Fitzpatrick R: Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire. Age Ageing 30:299-302, 2001
58. Rosenberg RN, Aminoff M, Boller F, et al: Reporting clinical trials: full access to all the data. Can J Neurol Sci 29:4, 2002
59. Rothman KJ, Michels KB: The continuing unethical use of placebo controls. N Engl J Med 331:394-398, 1994
60. Schulz KF: Subverting randomization in controlled trials. JAMA 274:1456-1458, 1995
61. Singer PA, Daar AS: Harnessing genomics and biotechnology to improve global health equity. Science 294:87-89, 2001
62. Slater EE: IRB reform. N Engl J Med 346:1402-1404, 2002
63. Smith R: Informed consent: edging forwards (and backwards). Br Med J 316:949-951, 1998
64. Staniszewska S: Patient expectations and health-related quality of life. Health Expect 2:93-104, 1999
65. Steel N: Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. Br Med J 320: 1446-1447, 2000
66. Steinbrook R: Improving protection for research subjects. N Engl J Med 346:1425-1430, 2002
67. Strull WM, Lo B, Charles G: Do patients want to participate in medical decision making? JAMA 252:2990-2994, 1984
68. Vreatch RM: From Nuremberg through the 1990's: the priority of autonomy, in Vanderpool HY (ed): The Ethics of Research Involving Human Subjects: Facing the 21st Century. Frederick, MD: University Publishing, 1996, pp 45-58
69. Weijer C: Placebo trials and tribulations. Can Med Assoc J 166: 603-604, 2002
70. Wells GA, Tugwell P, Kraag GR, et al: Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol 20:557-560, 1993
71. Yank V, Rennie D: Reporting of informed consent and ethics committee approval in clinical trials. JAMA 287:2835-2838, 2002